Consumption of antibiotics in the community, European Union/European Economic Area, 1997–2017: data collection, management and analysis
Author:
Bruyndonckx Robin12ORCID, Adriaenssens Niels13, Versporten Ann1, Hens Niel24, Monnet Dominique L5, Molenberghs Geert26, Goossens Herman1, Weist Klaus5, Coenen Samuel13ORCID, Strauss Reinhild, Vandael Eline, Sabtcheva Stefana, Payerl-Pal Marina, Kyriakidou Isavella, Vlček Jiří, Sönksen Ute Wolff, Linask Elviira, Sarvikivi Emmi, Cavalié Philippe, Feig Marcel, Kontopidou Flora, Benkő Ria, Aspelund Gudrun, Oza Ajay, Fortinguerra Filomena, Rutkovska Ieva, Kuklytė Jolanta, Bruch Marcel, Zarb Peter, Natsch Stephanie, Blix Hege Salvesen, Olczak-Pieńkowska Anna, Silva Ana, Iosif Ionel, Tesař Tomáš, Čižman Milan, Herreras Mayte Alonso, Bergfeldt Vendela, Hopkins Susan,
Affiliation:
1. Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium 2. Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Data Science Institute, Hasselt University, Hasselt, Belgium 3. Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium 4. Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium 5. Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden 6. Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Catholic University of Leuven, Leuven, Belgium
Abstract
Abstract
Objectives
This article introduces a series of articles on antibiotic consumption in the community between 1997 and 2017, which provide an update of previous articles covering the periods 1997–2003 and 1997–2009.
Methods
In this article, differences in participating countries, the ATC/DDD classification system, and data collection, validation and analysis between the current and previous series are described.
Results
In the previous series, 33 European countries provided valid data for further analysis, while the current series focused on 30 countries belonging to the EU or the European Economic Area (EEA). For both series, data were collected in accordance with the WHO ATC classification system. While the previous series reported data in accordance with the ATC/DDD index 2011, the current series employed the ATC/DDD index 2019. Both series focused on consumption of antibacterials for systemic use (ATC J01) and collected data expressed in DDD per 1000 inhabitants per day and packages per 1000 inhabitants per day. When studying consumption expressed in packages per 1000 inhabitants per day, countries reporting total care data, i.e. community and hospital sector combined, were included in the previous series but excluded in the current series. While the previous series used non-linear mixed models to evaluate time trends in antibiotic consumption, the current series allowed for inclusion of change-points with a data-driven location. In addition, both series assessed the composition and quality of antibiotic consumption in the EU/EEA.
Conclusions
The updated analyses of two decades of ESAC-Net data provide the most comprehensive and detailed description of antibiotic consumption in the community in Europe.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference39 articles.
1. Clinical impact and relevance of antibiotic resistance;French;Adv Drug Deliv Rev,2005 2. European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach;Vander Stichele;Br J Clin Pharmacol,2004 3. Decision No 1082/2013/EU of the European Parliament and of the Council of 22 October 2013;Off J Eur Union,2013
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|